Specialty
Aesthetics Cardiology Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Cardiology Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Search
Log In

Exploring Emerging Trends in Medical Glaucoma Management

By: Oluwatosin U. Smith, MD; and Jacob W. Brubaker, MD

Webinar Credits: 1.5

This webinar focuses on the newest therapies in glaucoma management and how their mechanisms of action and efficacy compares to traditional prostaglandins. The webinar also includes case discussions.

Expiration Date: Wednesday, September 13, 2023
Release Date: September 17, 2020

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Describe the mechanisms of action of novel therapeutics and classes of drugs
  • Compare the efficacy of novel therapeutics with traditional prostaglandins
  • Understand and explain the likelihood of achieving target intraocular pressure with monotherapy compared with combination regimens
  • Restate the most common side effects of novel therapeutics
  • Identify how to provide the best possible collaborative care when comanaging patients

Accreditation and Designation Statement

Provided by Evolve Medical Education

Accreditation Statement
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


Credit Designation Statement
Evolve designates this enduring. material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Sponsored by:

Evolve is an approved COPE Administrator.
This course is COPE approved for 1.5 hour of CE credit for optometrists.

COPE Course ID: 69550-GL
COPE Activity ID: 120213

 

Participation Method

In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS

Hardware Requirements:
4GB+ RAM

Recommended internet speed 5Mbps+

Faculty and Disclosures

Oluwatosin U. Smith, MD
Attending Clinician and Surgeon
Glaucoma Associates of Texas
Associate Professor Ophthalmology,
Department of Ophthalmology, UTSW Medical School
Dallas, TX

Jacob W. Brubaker, MD
Glaucoma and Anterior Segment Surgeon
Partner and CEO
Sacramento Eye Consultants
Sacramento, CA

 

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Jacob W. Brubaker, MD, and or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie, Allergan, Glaukos, Ivantis, and New World Medical. Grant/Research Support: Aerie, Allergan, Equinox, Glaukos, Ivantis, Nicox and Santen. Speakers Bureau: Aerie, and Allergan.

Oluwatosin U. Smith, MD and or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie, Allergan, Glaukos, Iridex, and New World Medical.  Grant/Research Support: Allergan, Glaukos, and Santen. Speaker’s Bureau: Aerie, Allergan, and Bausch + Lomb.

The Evolve staff and planners have no financial relationships with commercial interests.

Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Aerie.

Video Resources

BackNext

Test

Instructions

Step 1 of 2

  • a. 1b. 2c. 3d. 4e. 5
  • a. 1b. 2c. 3d. 4e. 5
  • AgreeNeutralDisagree
    Describe the mechanisms of action of novel therapeutics and classes of drugs
    Compare the efficacy of novel therapeutics with traditional prostaglandins
    Understand and explain the likelihood of achieving target intraocular pressure with monotherapy compared with combination regimens
    Restate the most common side effects of novel therapeutics
    Identify how to provide the best possible collaborative care when comanaging patients
Back